Stay updated on AXS-05 in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AXS-05 in Alzheimer's Agitation Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4. No other study details content appears to have changed.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now presents a consolidated Locations section and lists the states with clinical trial sites. This reorganizes site information to improve accessibility for potential participants.SummaryDifference1%

- Check44 days agoChange DetectedNew study sites added: Greenacres City, Florida; Sugar Land, Texas; Bayamón and San Juan, Puerto Rico. Some existing location entries were removed or relabeled during this update.SummaryDifference0.7%

- Check51 days agoChange DetectedNo changes to the trial’s design, eligibility criteria, or primary outcomes; updates consist of administrative metadata (Certification/Extension First Submitted, Certification/Extension Dates) and a revision label (Revision: v3.3.2) replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedRemoved the government funding operating-status notice from the page.SummaryDifference0.3%

- Check73 days agoChange DetectedThe comparison shows only minor layout adjustments with no addition or removal of core content. The study details, eligibility criteria, and location lists appear unchanged.SummaryDifference0.3%

Stay in the know with updates to AXS-05 in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-05 in Alzheimer's Agitation Clinical Trial page.